Jose Lozano Garcia, MD
Cardiovascular Disease · Corvallis, ORNPI 1508204405
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $19,132 of the $30,710 with a category attached, or 62.3%. 14 manufacturers reported payments, led by Abbott at 30.5% of the total. Reporting peaked in 2022 at $16,195 and has fallen 78.8% since, to $3,440 in 2025. Among cardiovascular disease clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $131.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Medtronic$9K
- Biotronik Inc.$7K
- Boston Scientific$4K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$624
- Medline Industries LP$430
- plus $822 from 8 others
What the payments were for
- Travel & lodging$19,13262%
- Food & beverage$10,26133%
- Education$1,3184%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 67 | $9,377 |
| Medtronic | 81 | $8,641 |
| Biotronik Inc. | 29 | $6,918 |
| Boston Scientific | 18 | $3,898 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $624 |
| Medline Industries LP | 4 | $430 |
| Abiomed | 2 | $184 |
| Johnson & Johnson | 8 | $158 |
| Pfizer | 1 | $107 |
| Edwards Lifesciences | 1 | $106 |
| Astellas Pharma US Inc | 1 | $102 |
| AstraZeneca | 1 | $100 |
| Philips North America LLC | 1 | $47 |
| Teleflex LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$4,325
- GENERAL - THERAPIES$2,826
- ENSITE$2,542
- Micra$1,379
- Edora 8 DR-T$1,280
- BioMonitor$1,171
- Rivacor 7 DR-T$1,171
- Acticor 7 VR-T DX$1,171
- Solia$1,069
- VersaCross Access Solution$859
- CARDIOBLATE CRYOFLEX$743
- ARCTIC FRONT ADVANCE$664
- HeartMate 3 Left Ventricular Assist Device$205
- Impella$115
- AURORA EV-ICD MRI SURESCAN$111
- VYNDAQEL$107
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$106
How this compares
$30,710 in reported general payments places this provider in the 90th percentile of 198 cardiovascular disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 13 | $215 |
| Metoprolol Succinate | 18 | $179 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Corvallis
- Ashwat DhillonCorvallis$156K
- William StouttCorvallis$7K
- Edward ToggartCorvallis$3K
- Firas ZahrPortland$810K
- Kathy GreweHood River$376K
- Scott ChadderdonPortland$282K
- Ahmad MasriPortland$227K
- Stephen HeitnerPortland$105K
- Ian RiddockBend$81K
- Abhushan PoudyalPortland$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.